Although all patients with SLE had levels above the threshold, dysfunction of C4 or the presence of complement inhibitors in SLE plasma cannot be excluded, because MBL-induced complement activity is reduced in our patients. This evidence concerns the gene C4A and systemic lupus erythematosus.